NO20014221D0 - Fremgangsmåte for behandling av anstrengelses-indusert astma - Google Patents

Fremgangsmåte for behandling av anstrengelses-indusert astma

Info

Publication number
NO20014221D0
NO20014221D0 NO20014221A NO20014221A NO20014221D0 NO 20014221 D0 NO20014221 D0 NO 20014221D0 NO 20014221 A NO20014221 A NO 20014221A NO 20014221 A NO20014221 A NO 20014221A NO 20014221 D0 NO20014221 D0 NO 20014221D0
Authority
NO
Norway
Prior art keywords
exertion
treating
induced asthma
asthma
induced
Prior art date
Application number
NO20014221A
Other languages
English (en)
Other versions
NO20014221L (no
Inventor
Richard Nieman
Theodore Torphy
Siegfried Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20014221D0 publication Critical patent/NO20014221D0/no
Publication of NO20014221L publication Critical patent/NO20014221L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20014221A 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma NO20014221L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12246499P 1999-03-01 1999-03-01
US14129199P 1999-06-28 1999-06-28
PCT/US2000/005363 WO2000051599A1 (en) 1999-03-01 2000-03-01 Method for treating exercise induced asthma

Publications (2)

Publication Number Publication Date
NO20014221D0 true NO20014221D0 (no) 2001-08-31
NO20014221L NO20014221L (no) 2001-10-24

Family

ID=26820540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014221A NO20014221L (no) 1999-03-01 2001-08-31 Fremgangsmåte for behandling av anstrengelses-indusert astma

Country Status (19)

Country Link
US (1) US6555576B1 (no)
EP (1) EP1156800A4 (no)
JP (1) JP2002538115A (no)
KR (1) KR20010102460A (no)
CN (1) CN1350453A (no)
AR (1) AR035987A1 (no)
AU (1) AU3715000A (no)
BR (1) BR0008625A (no)
CA (1) CA2366041A1 (no)
CO (1) CO5150236A1 (no)
CZ (1) CZ20013148A3 (no)
HK (1) HK1043727A1 (no)
HU (1) HUP0200026A3 (no)
IL (1) IL144996A0 (no)
NO (1) NO20014221L (no)
NZ (1) NZ513697A (no)
PL (1) PL352822A1 (no)
TR (1) TR200102515T2 (no)
WO (1) WO2000051599A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY121142A (en) * 1999-02-23 2005-12-30 Smithkline Beecham Corp Controlled release formulation for treating copd
WO2001032165A1 (en) * 1999-10-29 2001-05-10 Smithkline Beecham Corporation Method for administering a phosphodiesterase 4 inhibitor
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
PT1425001E (pt) 2001-09-14 2009-02-18 Glaxo Group Ltd Derivados de fenetanolamina para o tratamento de doenças respiratórias
GB0201677D0 (en) 2002-01-25 2002-03-13 Glaxo Group Ltd Medicament dispenser
AU2003286143A1 (en) 2002-10-28 2004-05-13 Glaxo Group Limited Phenethanolamine derivative for the treatment of respiratory diseases
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
TW200503706A (en) * 2003-03-31 2005-02-01 Kyowa Hakko Kogyo Kk Treating and/or preventing agent for pulmonary diseases
GB0317374D0 (en) 2003-07-24 2003-08-27 Glaxo Group Ltd Medicament dispenser
EP1699436A2 (en) * 2003-12-12 2006-09-13 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
US20060025463A1 (en) * 2004-03-22 2006-02-02 Michael Bristow Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
EP1737447A1 (en) * 2004-03-22 2007-01-03 Myogen, Inc. (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
CA2572179A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
GB0418278D0 (en) 2004-08-16 2004-09-15 Glaxo Group Ltd Medicament dispenser
PE20061351A1 (es) 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
GB0515584D0 (en) 2005-07-28 2005-09-07 Glaxo Group Ltd Medicament dispenser
GB0525337D0 (en) * 2005-12-13 2006-01-18 Novartis Ag Organic compounds
GB0622827D0 (en) 2006-11-15 2006-12-27 Glaxo Group Ltd Sheet driver for use in a drug dispenser
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
WO2018094392A1 (en) 2016-11-21 2018-05-24 Lupin Inc. Medicament dispenser
WO2019195711A1 (en) 2018-04-06 2019-10-10 Lupin Inc. Medicament dispenser
WO2020058823A1 (en) 2018-09-17 2020-03-26 Lupin, Inc. Dose indicator assembly for a medicament dispenser
BR112022019277A2 (pt) 2020-03-25 2022-12-06 Lupin Inc Distribuidores de medicamentos multi-portadores
CA3186551A1 (en) 2020-07-23 2022-01-27 Lupin Inc. Dose counter assemblies for medicament dispensers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU677776B2 (en) * 1992-04-02 1997-05-08 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases

Also Published As

Publication number Publication date
AR035987A1 (es) 2004-08-04
EP1156800A4 (en) 2004-11-24
HK1043727A1 (zh) 2002-09-27
IL144996A0 (en) 2002-06-30
WO2000051599A1 (en) 2000-09-08
PL352822A1 (en) 2003-09-08
BR0008625A (pt) 2002-02-19
US6555576B1 (en) 2003-04-29
NZ513697A (en) 2001-09-28
HUP0200026A2 (hu) 2002-05-29
CO5150236A1 (es) 2002-04-29
NO20014221L (no) 2001-10-24
CA2366041A1 (en) 2000-09-08
CN1350453A (zh) 2002-05-22
JP2002538115A (ja) 2002-11-12
KR20010102460A (ko) 2001-11-15
AU3715000A (en) 2000-09-21
EP1156800A1 (en) 2001-11-28
CZ20013148A3 (cs) 2002-08-14
HUP0200026A3 (en) 2003-03-28
TR200102515T2 (tr) 2002-04-22

Similar Documents

Publication Publication Date Title
NO20014221D0 (no) Fremgangsmåte for behandling av anstrengelses-indusert astma
NO20030241D0 (no) Fremgangsmåte for behandling av multiple brönnintervaller
NO20014960L (no) Nye fremgangsmåter for behandling
NO20011121D0 (no) FremgangsmÕte for formasjonsbehandling med deformerbare partikler
NO20015547L (no) Fremgangsmåte for hemisyntese av forbindelser og nye forbindelser
DK0841946T4 (da) Metoder til behandling af allergisk astma
NO20010117D0 (no) Fremgangsmåte for behandling av sövnlöshet
AU2003283958A8 (en) Method of treating tremors
EP1422297A4 (en) METHOD FOR TESTING BRONCHIAL ASTHMA
NO20033192L (no) Fremgangsmåte for behandling av dopamin-relaterte dysfunksjoner
ID30430A (id) Senyawa-senyawa dan metode-metode untuk pengobatan gangguan-gangguan asma, alergi dan inflamasi
AU2002231836A1 (en) Method for treating and drying of wood
NO20014222D0 (no) Fremgangsmåte for behandling av COPD
AU2002365814A8 (en) Method of treating asthma
AU3757300A (en) Method of treating anxiety disorders
SE0101676D0 (sv) Method and apparatus for treating pulp
PT1051172E (pt) Metodo para tratamento da dpco
NO20015162D0 (no) Fremgangsmåte for behandling av nevrodegenerering
AUPR381601A0 (en) Method of treating respiratory conditions
FI991036A (fi) Tomosynteesimenetelmä ja laite tomosynteesikuvantamisessa
AU2003235939A1 (en) Method of treating condensate and apparatus
HUP0105152A3 (en) Method for treatment of headache
NO20001985L (no) FremgangsmÕte for forming av strimmelformede folier
HU0303170D0 (en) Method for the production of 2-coumarone and substituted 2-coumarones
GB0221350D0 (en) Method of treating asthma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application